Form 4: IGM Biosciences Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Chris H. Takimoto, Chief Medical Officer of IGM Biosciences, sold 1,487 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On September 13, 2024, Chris H. Takimoto, the Chief Medical Officer of IGM Biosciences, sold 1,487 shares of the company's common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $11.5388, with individual trades ranging from $11.20 to $11.795.
- Following the transaction, Takimoto directly owns 154,331 shares of IGM Biosciences common stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (sale of shares for tax obligations) and does not contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and officers.
Key Dates
| Date | Description |
|---|---|
| 09/13/2024 | Date of the stock sale transaction. |
| 09/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.